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Gendering the Therapeutic Citizen:  
ARVs and Reproductive Health 
Abstract 
Reproductive Health as a global agenda can provide an opportunity for 
including “social issues” under its vast umbrella.  However, so far reproductive 
health has failed to go beyond family planning in large-scale, high impact 
interventions.  Now, the impact of the HIV/AIDS pandemic has meant that the 
primary reproductive health goal of many African women in highly affected 
communities is to remain healthy long enough to reproduce. The case of ARV 
treatment in a township clinic in South Africa will demonstrate the need for a 
genuinely integrated global concept of reproductive health and rights that 
includes the realities of AIDS and its treatment.  This research is in some 
respects an anthropological examination of AIDS interventions from a political 
standpoint. In this paper I examine the other side of the issue of AIDS and family 
planning integration: how are family planning technologies and contraceptive 
decision making integrated into HIV/AIDS treatment clinics?  Reproductive 
decision making in the context of the AIDS clinic reignites classic debates over 
the rights of the individual versus the rights of the community, the meanings of 
motherhood and maternal identity, and the appropriate control of sexuality by 
the state vis a vis governance of the self.  Yet, in the situation of reproductive 
decision making by HIV positive women, the stakes are higher, the boundaries 
less discernible, and the meanings even more contingent by the urgency of the 
disease and the poignancy of the processes of giving life. To begin to understand 
this, I argue, we must find a way to gender the therapeutic citizen in order to 
reintegrate the biopolitical struggle of ARVs with the “social issues” 
percolating within the therapeutic state.   
Introduction 
Globalisation is an econo-technological institutional process with a pervasive 
impact.  It has brought technological access to the forefront of political debates 
over global inequality.  In high-income countries, antiretroviral treatment 
(ARVs) became widely available in 1996, and AIDS-related mortality dropped 
sharply.  UNAIDS reported similar trends in Brazil and predicted that we would 
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see similarly declining mortality rates in countries in Latin America, the 
Caribbean and Africa (UNAIDS, 2002).  In contrast to conventional wisdom 
that anti-retroviral therapies would remain beyond the reach of most HIV 
positive people in developing countries, improving access to anti-retroviral 
drugs has become officially a global priority.  While this has yet to be realised in 
most African countries, South Africa has undertaken the largest public ARV 
treatment programme in the world.    
Reproductive health and rights agendas have focused attention on important 
issues that had not been emphasised in population debates: who controls 
fertility, reproductive decision-making, the ethics of contraceptive methods and 
the impact of gender relations in the household, clinic and national policy 
environment.  Reproductive health as a global agenda can provide an 
opportunity for including “social issues” under its vast umbrella.  However, so 
far reproductive health has failed to go beyond family planning in large-scale, 
high impact interventions.  National reproductive health programs in developing 
countries are implemented through the same structures of the old population 
interventions.  Yet, when global discourses are translated in local contexts of 
HIV/AIDS, reproductive health in many African communities might be best 
understood as remaining healthy enough to reproduce.  South Africa has one of 
the highest rates of contraceptive use and the lowest fertility rates in Africa, yet 
the gendered importance of childbearing persists perhaps both in spite of and 
because of the omnipresence of HIV/AIDS.  An exploration of AIDS and 
contraceptives in South Africa cannot take place outside the macro-context of 
race, political struggle, state-building, and the economic realities of 
contemporary South Africa, best characterised by poverty, “empowerment” 
extremes1, and gross and gaping inequality, known as the “distributional 
regime” (Seekings and Nattrass 2006).   
In other work, I have explored how HIV/AIDS is integrated into family planning 
in African reproductive health clinics (Richey 2003; 2005; 2006).  I argue that a 
population discourse dominated by concern for female fertility control precludes 
adequate incorporation of the challenges that AIDS brings to healthcare 
provision and development policies.  I remain interested in continuing my 
explorations with how “scientific practices seep unevenly through the crossroads 
and chasms at which biotechnology and family life conjoin” (Rapp 1998, 68).  
Further, looking through a local clinic case study is conducive toward rethinking 
the way that health policy, international interventions and global priorities are 
performed.  In this paper I examine the other side of the issue of AIDS and 
family planning integration: how are family planning technologies and 
contraceptive decision making integrated into HIV/AIDS treatment clinics?  
                                                 
1   This refers to the contemporary debates surrounding “Black Economic Empowerment” or 
“BEE” which are beyond the scope of this paper.   
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While this has not yet become a central topic of public health interest, women 
on ARVs will make it one.   
Bayer argues that “AIDS has represented a challenge to the central impulse of 
liberal individualism, forcing into the social realm matters that had come to be 
viewed as of no legitimate public concern; it has revealed the limits of the 
ideology that had provided the wellspring of cultural and political reform” 
(1990, 179).  Reproductive decision making in the context of the AIDS clinic 
reignites classic debates over the rights of the individual versus the rights of the 
community, the meanings of motherhood and maternal identity, and the 
appropriate control of sexuality by the state vis a vis governance of the self (cf. 
Glenn, Chang and Forcey 1994).  The self on ARVs as linked to the geopolitical 
realm of AIDS treatment both globally and locally has been termed the 
“therapeutic citizen” (Nguyen 2004).  Yet, in the situation of reproductive 
decision making by HIV positive women the stakes are higher, the boundaries 
less discernable, and the meanings even more contingent by the urgency of the 
disease and the poignancy of the processes of giving life.  To begin to 
understand this, I will argue, we must find a way to gender the therapeutic 
citizen in order to reintegrate the biopolitical struggle of ARVs with the “social 
issues” percolating within the therapeutic state.   
Methodology 
This research is in some respects an anthropological examination of AIDS 
interventions from the standpoint of politics and policy. The empirical material 
for this paper comes from fieldwork in the Western Cape Province of South 
Africa from June until December 2005.  I conducted interviews, attended 
meetings and seminars and consulted local researchers within the Province on 
the “roll-out” of ARVs and issues of access and adherence.  In the process of 
researching the local politics of access to ARVs, I became most interested in the 
participant observation work I was permitted to conduct at the Heshima Clinic2 
for HIV/AIDS treatment on which most of this paper will draw.3  Together with 
my Xhosa translator,4 I sat in on adherence counseling sessions, ARV 
information sessions, and home visits conducted by patient advocates as part of 
the patient “work-up” for initiating ARVs.  I also interviewed the various types 
of service providers affiliated with the ARV programme, engaged in 
unstructured observation at the clinic, attended the weekly meetings of the ARV 
                                                 
2   A pseudonym.  
3   I am grateful to the Metropole Region of the Western Cape for research clearance for this 
project.   
4   To whom I am much indebted for her insight and extensive experience with research, 
provision of care, and individual negotiations around AIDS treatment.   
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treatment team and observed patients’ visits to the physicians, which took place 
in English.  
The clinic is my site of inquiry because of its unique position as a site of 
translation and struggle between high modernist discourses of medicine, 
neoliberalism and “development” and national discourses of cultural, Africanist, 
traditional medicines (sangomas), economic apartheid, and global discourses of 
abjection (Ferguson 1999; Kristeva 1982).5 My work differs from medical 
anthropology in that the clinic provides a way of examining the interactions 
between the state and its citizens.  It is the most “local” of my methodological 
inquiries; even though I visited homes and interviewed individuals, these 
interactions stemmed from the clinic.  
The clinic where I have worked is hardly a neutral geographical site.  Consisting 
of a smallish, well-kept cement building, four prefabricated “bungalow” 
annexes, an AIDS support group’s fledgling vegetable garden, and parking 
space for about five cars within a high chain-link fence, it is a highly politicised 
space.  Patients, service providers and researchers enter at their own, varied, 
risk. Everyone in the township knows that this used to be the mother and baby 
clinic and now it is the AID clinic, although the sign outside says something less 
descriptive.  Within the chain-link fence, power is legitimately wielded by the 
state.6  The inhabitants are commissioned with the authorised use of medicine.   
Furthermore, in the province that least frequently resembles an integrated 
picture of the New South Africa’s “rainbow nation,” the clinic is a space of 
legitimate socio-racial-culture contact, if not equal exchange.  Doctors (and 
researchers) drive in from Cape Town’s leafy suburbs; counselors and nurses 
come from other townships or “mixed” geographical spaces, and patient 
advocates come from the diverse localities around the clinic’s township area.  
Patients come from the local township, from other townships, or from other 
poorer parts of the country.  There is no residency requirement for ARV 
treatment, just a commitment to return to the clinic for the required regular 
follow-up visits.  The clinic provides the rare opportunity to examine the 
interesting mixes of different agendas that cut across lines of race, class and 
South African history.   
                                                 
5   Of course I am merely following a distinguished tradition in medical anthropology in my 
fascination with the clinic, but for some reason this site of biopolitical struggle is not central 
to much of the political science or development studies research.   
6   I assume, with some hesitancy, that a notion of the “state” can be made relevant in spite of 
the vastly different and conflicting policies and politics between the national, provincial and 
regional levels of government that link this clinic to the system.   
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Rights, Reproductive Health and “Social Issues” of 
ARVs 
The global development perspective on HIV/AIDS control in Third World 
countries has shifted away from rights and individual liberties, moving toward a 
greater emphasis on control and public good.  The pandemic is represented as 
becoming increasingly unmanageable, and AIDS activists’ successful demand 
for more access to treatment has, in some instances, resulted in backlash.  For 
example, former US President Bill Clinton is quoted in the popular media as 
supporting universal HIV testing in developing countries with high levels of 
HIV infection, like that done in Lesotho.7  Academically, a special issue of the 
Journal of International Development dealing with HIV/AIDS policies 
concludes that “enforced testing, enforced use of condoms, segregation of those 
who are positive, and perhaps enforced compliance with antiretroviral regimes:  
these are strategies which would have an effect” (Allen 2004, 1127).  The editor 
acknowledges that such strategies involve “what might be regarded as 
infringements of civil liberties” but justifies that the human rights of those who 
are HIV positive have been privileged over the rights of those who are negative, 
and this is “potentially counterproductive” for public health (Ibid.).  The 
argument throughout the volume is that Third World country contexts require 
extraordinary interventions and human rights may have to be compromised.  
Nowhere does the work explicitly outline whose rights are to be privileged, and 
nowhere is it explicitly acknowledged that such triage decision-making would 
be quite likely to exacerbate existing societal inequalities based on gender, class, 
ethnicity, religion or sexual orientation.  As I will demonstrate from my clinic-
level work, poor women on public ARV programmes are unlikely to be in a 
position to navigate the obstacles that stand in the path of exercising meaningful 
reproductive choices between the individual and the state.  Thus, the impact of 
AIDS policies must be considered within the “social issues” of poverty.  An 
explicit recognition and analysis of “social issues” provides a means of 
appreciating the efforts taken by therapeutic citizens in negotiating within them.8   
Family planning decision making for women with AIDS destabilizes the 
philosophical foundations of reproductive choice, while simultaneously 
providing a global call-to-arms in defense of the very rights that are rendered 
hollow in the “social issues”:  daily techno-battles for well-being and 
                                                 
7   “Clinton calls for rethink in universal HIV testing” Thursday 30 March 2006, AIDSMAP 
news (found at www.aidsmap.com/en/news/D5CBB09D-9940-4BFD-8FE8-
54085F9CBB11.asp?type=preview). 
8   One reason that these debates may have been bracketed is that they were often used as 
justifications for denying treatment to poor people, as it was incorrectly argued that the poor 
could not manage such a complicated regime.  These debates have been resolved in so far as it 
is no longer a question of whether to bring ARV treatment to the poor, but how to do so.   
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biopolitical citizenship.  The insight of the reproductive health agenda – 
particularly the synergy between reproductive health, empowerment and the 
right to health care – is not easily incorporated into the existing behavioralist 
models of HIV/AIDS interventions (Richey 2003). A situation analysis meant to 
outline the “critical relationships” between family planning and reproductive 
health programmes and HIV/AIDS in South Africa never even mentions the 
need of HIV positive women for reproductive health services (Advance Africa 
2002).  It concludes with the “lesson learned” that “the relationship between 
family planning, which deals with birth, and HIV/AIDS which deals with death, 
is complex” (Ibid., 19). 
Questions of rights, reproductive decision-making and “social issues” are 
negotiated within the practice of AIDS treatment counseling.  Globally, the 
trend toward “nondirective” counseling can be traced to the new forms of social 
work that developed in the 1970s to support genetic counseling. These new 
counseling forms were purposefully elaborated as distinct from, and in 
opposition to, the heritage of eugenics that had lost political and social 
approbation after WWII.  “Nondirective counseling” was meant to be “a type of 
social work entirely for the benefit of the whole family without direct concern 
for its effect upon the state or politics” (Reed 1974, 336, cited in Bayer 1990, 
184).  In spite of is discordance with the traditions of clinical medicine at the 
time, nondirective counseling quickly became the hegemonic discourse.  It 
profoundly shaped notions of counseling in the context of both US national 
policy and practice and in international health (Bayer 1990, 185).9  This notion 
of nondirective counseling for genetic disorders coalesced nicely with the 
foundational elements of liberal feminism that women must be permitted to 
control their own reproductive lives and such liberty required a strong 
ideological attachment to notions of individual choice. Thus, nondirective 
counseling which focused on providing individuals with the knowledge 
necessary to make informed choices about their health was the standard that was 
meant to apply to family planning counseling, and to some extent to counseling 
for HIV testing and later AIDS treatment.   
However, the cozy consensus on liberal choice was shattered by the problem of 
vertical transmission of HIV.  As a result, the terrain of individual choice within 
reproductive decision-making was littered with ideological shrapnel, and de-
mining efforts continue in global, national and local fields.  The issue of vertical 
transmission was first addressed at the US Centers for Disease Control (CDC) in 
December 1985 and a recommendation was made that “Infected women should 
be advised to consider delaying pregnancy until more is known about perinatal 
transmission of the virus” (Bayer 1990, 189).  This statement represented a 
                                                 
9   I refer to the US national context here as it has been for decades the global public health 
hegemon, particularly in reproductive health and HIV/AIDS (see Sharpless 1997).  
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dramatic break from all previous “nondirective” endeavors to support individual 
choice in the reproductive, private realm and instead it applied standard public 
health norms.  Bayer emphasises that the tentative language used conveyed a 
less drastic impression of what was happening, as women were advised to 
“consider” the “delaying” of pregnancy; yet the preventive orientation actually 
required a fundamental curtailment of their reproductive lives (1990, 190-91).   
The official discourse shift here was no doubt shaped by US public opinion, 
with global repercussions.  The March of Dimes, a US charity established in 
1938 to combat polio, had an explicit policy against directive counseling of 
women at risk for bearing children with birth defects. Yet, when HIV was the 
possible defect the entire perspective changed.  A television spot in the US 
showed a baby-like marionette whose strings are cut by a pair of scissors, while 
an off-camera voice announced:  “A baby born with AIDS is born dying” (Ibid., 
195).  What is important here is that HIV radically altered the notions of 
reproduction, its location in the public versus private domain and notions of the 
individual as rights bearer in ways that no other disease, defect or disorder had 
done.   
In this paper, I analyse how various interwoven levels of political imperatives 
call forth performances of therapeutic citizenship, dancing between the policy 
level (does the state matter?) and the local moral economy of the clinic.  This 
work has been inspired in part by Randall Packard’s (1989) book, White Plague, 
Black Labour: Tuberculosis and the Political Economy of Health and Disease in 
South Africa, which blends a political economy of disease and health care with 
an analysis of medicine as an ideological construct.  Packard’s contention for the 
case of TB can frame a useful critical perspective for analysis of HIV/AIDS in 
contemporary South Africa.  He argues that “the South African experience with 
TB had not been produced by a unique set of social and biological phenomenon 
(either the racist state or the racially susceptible Africa).  It must be seen instead 
as a product of a particularly pathological intersection of political, economic and 
biological processes that have a much wider distribution” (Packard 1989, 19).   I 
will expand his line of vision to include the HIV/AIDS pandemic in which 
South Africa is neither typical nor exemplary.   
Additionally, I draw conceptually on Vinh-Kim Nguyen’s discussion of the 
complex, biopolitical assemblage of HIV/AIDS that has been able to stitch 
together apparently disparate phenomena such as condom demonstrations, CD4 
counts, sexual empowerment, compliance with drug regimes, retroviral 
genotyping, an ethic of sexual responsibility into a remarkably stable, worldwide 
formation (Nguyen 2004).  “Therapeutic citizenship” is a biopolitical construct 
based on a system of claims and ethical projects that arise out of the conjugation 
of techniques used to govern populations and manage individual bodies.  
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Therapeutic citizens operate within a therapeutic economy (the totality of 
therapeutic options in a given location and the rational behind legitimate access 
to them) –this may be structured by monetary exchange but is also embedded 
within “regimes of value” (moral economies, networks, patronage, etc.) (Ibid.).  
Therapeutic citizenship is useful for placing personal negotiations of illness 
within an explicitly political and institutional framework.  Linking moral 
obligations with economic imperatives in a way that emphasises relationships 
and interactions, therapeutic citizenship provides us with a way of thinking 
about the individual and the collective.   
However, further work is needed to conceptualise the therapeutic citizen, 
specifically as it relates to a particularly gendered notion of citizenship. Vinh-
Kim Nguyen himself described an “unexpected challenge” to his clinical work 
as a physician providing ARVs in the Ivory Coast:  women who got healthier 
returned to sexual life and childbearing.  This turned up in the clinic as an 
“adherence problem.”  Women would disappear from the clinics and come back 
nine months later with a baby.  Nguyen explained that one of the nurses had 
summed up why the women felt they had to hide to reproduce:  “It’s not 
authorized to get pregnant when you are on treatment.”10  Can it be possible for 
women in a culture of nearly universal childbearing and high levels of 
reproductive desire to act as therapeutic citizens within the ARV context?  To do 
so, we must gender the therapeutic citizen.  This paper will explore how we can 
gender the therapeutic citizen through an understanding of reproductive decision 
making by women on ARVs within a South African AIDS clinic.   
Pregnant Women, ARVs and Motherhood 
ARV treatment presents interwoven, relationships of treating the self and the 
mother—representing a new twist on the historical feminist debates between the 
self, the fetus and the maternal relationship.  Exposure to pregnancy necessarily 
risks exposure to HIV, as procreation involves unprotected sexual intercourse.11  
As we will see from discussions of the clinic interactions, there is in effect, an 
implicit separation between procreative sexual relations and all other types of 
sexual behavior.  The former, are being governed by appropriate consultative 
processes between the therapeutic citizen and her physician, and the latter, are 
under strict control of the condom.   Yet, this separation between the mother and 
the sexually active woman is not only illogical (you cannot tell women that they 
                                                 
10   From a talk by Vin-Kim Nguyen at Copenhagen University 18 May 2006.   
11  This anxiety has become the focus of a new technofix in Kenya where currently 
newspapers are full of the story of the “historic achievement of In Vitro fertilization” where it 
is now possible to “wash a man’s sperm to rid it of the HIV virus before fusing it with a fertile 
embryo and implanting it in a womb” (The East African Standard, 11 May 2006).   
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must use a condom every time they have sex to protect themselves from 
reinfection with a resistant virus and to protect their partner, and at the same 
time advise them to plan pregnancies with their physician), it represents a 
fundamental difficulty of gendering the therapeutic citizen.   
Women who are pregnant are accorded special status in the global hierarchy of 
ARV allocation.  They are assumed to be the ones most in need of treatment, not 
for their own virus, but for the potential transmission to their fetus, capture of 
their family into treatment regimes and care of their children.  There are three 
points of intersection between ARV treatment and pregnant women:  pregnant 
women are to be given ARVs for the prevention of “maternal-to-child 
transmission”12 of HIV; pregnant women are meant to provide an entry point to 
family care; and pregnant women are entitled to ARVs as a means to extend 
their own lives for the sake of preventing AIDS orphans (see McIntyre 2005).   
In fact, it was the pregnant woman lacking in ARV access that epitomised the 
recent documentation of the failings of the World Health Organisation’s global 
“3 by 5” initiative.  The headlines read: “ARVs Missing Pregnant Women –
WHO.”13  The report of the shortcomings of the 3 by 5 began: “Fewer than 10 
percent of HIV-positive women in developing countries received antiretrovirals 
(ARVs) during pregnancy and childbirth between 2003 and 2005, according to a 
new report . . . 1,800 children per day were born with HIV. . . over 570,000 
children under the age of 15 die of AIDS, most having acquired HIV from their 
mothers” (Ibid.).  This global construction of the sacrifices of motherhood is 
insidious, concealed behind the banal language of development statistics.  
Centering the gaze on the “pregnant woman” who did not receive ARVs, it 
shields the virtuous fetal citizen, constructed by default through the focus on the 
pregnancy.  The rhetorical concealing of both the fetus and the woman, through 
the “pregnant woman” status is politically efficacious.  Holc (2004) draws on 
the discourses of abortion in Poland to argue that the construction of fetal 
persons acts as process of subject formation that results in particular effects on 
other subjects.  “The mythology of the personhood of the fetus gradually effaces 
another personhood – that which should be attributed to women” (Graff 2001, 
cited in Holc 2004, 766).  However, the woman on ARVs is conspicuously 
absent from the PMTCT imaginary.  Reinserting her into these discourses would 
confront us with both the possibility and even likelihood that AIDS-infected 
                                                 
12 The term “mother-to-child transmission” is obviously problematic and epitomises the 
discursive focus on motherhood, and the mother’s ultimate failure to protect her child from 
harm by transmitting her own disease to an innocent victim.  Unless I am referring to other 
discourses, I use the term “vertical transmission” in this paper to redirect the concept toward 
the actual process of viral transmission, not the responsible or irresponsible agents.   
13 UN Integrated Regional Information Networks, 29 March 2006. 
http://www.aegis.com/news/irin/2006/IR060385.html, last accessed 27 Oct.2006. 
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women will reproduce like other women, and that a responsibility for treating 
the mother is ethically inherent in PMTCT, whether or not this is cost-effective 
in the public policy realm.   
Mapping the Local Terrain of a Township in Western 
Cape Province, South Africa 
It would be naïve to surmise that equitable systems for providing life-saving 
drugs could exist outside their historical context of overlapping indices of 
inequality.  Global political economy, race/ethnicity, gender, regionalism, 
religion, nationalism and politics will all impact the way that the ubiquitous 
“roll-out” of ARVs will take place in developing countries.  Furthermore, 
gendered constructions of the therapeutic citizens of the ARV state will serve 
multiple, if perhaps predictable agenda.  For example, a doctor at a different 
clinic in the Western Cape characterised the ways in which “men are more likely 
to take a macho denialist approach,” but women “as caregivers are more 
immediately and forcefully concerned with their own health” (Casey 2005, 50).   
The South African state-sponsored family planning programme officially began 
in 1974, a time of rapid urbanisation and forced resettlement of the Black 
population into ‘homelands’, vast labour migration, rising levels of 
unemployment and increasing militancy by non-whites against the apartheid 
regime (Kaufman 2000, 105).  While the programme was officially non-racial, 
most research emphasised the provision of family planning with the state’s 
desire to control the Black and Coloured population (Brown 1983 and 1987, 
Chimere-Dan 1993, Klugman 1993 cited in Kaufman 2000).  Still, ever-
increasing numbers of Black women have been adopting contraception for as 
long as data has been available.  South Africa has extremely high levels of 
contraceptive use, with 75% percent of women having ever used contraceptives 
and 50% currently using a modern method according to 1998 Demographic and 
Health Survey data.  Kaufman concludes:  “Economic conditions, employment 
opportunities and concern for the health and welfare of their families within the 
context of a racialized society have motivated black South African women to 
use contraceptives in spite of immense pressure, real or assumed to do 
otherwise” (Kaufman 2000, 113).   
My analysis draws on a South African Case study from a vertically-structured, 
multi-sited ethnography.  It begins in the Heshima AIDS clinic, located within 
the Provincial Government of the Western Cape, and also within the National 
context of President Mbeki, Health Minister Manto and “denialism.”14  In brief, 
                                                 
14   Forthcoming work from this project will analyse the national dimension of denialism in 
relation to the case study presented, but it is beyond the scope of this paper. 
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South Africa probably has more than 5 million people living with HIV/AIDS - 
the highest number of any country in the world.15  The national government is 
notorious for its lack of leadership on AIDS issues and for its President’s 
questioning of the link between HIV and AIDS, accusing scientists of racism 
and ARVs as poison and supporting regimes of African potatoes and garlic as 
good alternatives to ARVs for AIDS treatment (see Nattrass 2004).  
Whenever South Africa is taken as a case of “African” AIDS, it must be restated 
that the country has a Gross Domestic Product (GDP) of 104 billion USD in 
2002 figures.  Of all Southern African countries it is followed in wealth levels 
by Angola with a GDP barely reaching into the double digits of only 11 billion 
USD.  It is simply not a poor country, but also a middle-income country like 
Brazil.  The multiple and varied characterisations of South Africa as “poor” or 
“middle-income”, and as running parallel to Europe or to Africa, serve highly 
political purposes.  
With due recognition to the political complexity of the case and its data, a 
genuine attempt to map the local official terrain of ARVs follows.  On 19 
November 2003, the South African Government published the Comprehensive 
Plan on HIV/AIDS Care, which aims to provide universal coverage of ARVS 
within five years.  This remarkable document is read as either marking the 
victory of civil society demands for public availability of ARVs, or as yet 
another stalling tactic by the recalcitrant National government for its inflated 
targets and lack of a workable implementation plan.  Monitoring South Africa’s 
public ARV programme has involved confrontations between civil society and 
the national government, with provincial ministries playing on various sides. A 
recent assessment of the roll-out by a University of Cape Town Economist on 
the basis of data collected by the country’s premier demographic model 
(ASSA2003) argues that “South Africa may have one of the largest HAART 
programmes (as claimed by President Mbeki in his 2006 State of the Nation 
address).16  However, given its resource endowments, this programme should be 
even bigger” (Nattrass 2006, 3).   
Policy progress is measured according to “roll-out” rates. These rates represent 
the percent of people who progress to AIDS and get ARVs.  By the end of 2005, 
national HAART coverage was approximately 25% (meaning that only one in 
four people who would need HAART are receiving it) (Nattrass 2006, 5).  The 
actual number of people on treatment was approximately 124,000 in mid-2005.   
                                                 
15   The HIV prevalence statistics are notoriously ideologically biased; reputable statistics 
from different sources vary by more than a million people in their estimates of the number of 
South Africans living with HIV. 
16 Mbeki, Thabo. (2006) State of the Nation Address.  Available on 
http://www.anc.org.za/ancdocs/history/mbeki/2006/tm0203.html, last accessed 27 Oct.2006.  
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There are significant differences between the provinces.  Some provinces have 
exceeded a 50 per cent roll-out, but there are huge variations with worst-
performing provinces (Mpumalanga, Free State and Limpopo) covering barely 
20 per cent of those who need care.  For example, in mid-2005, it was reported 
that Limpopo Province had no accredited HAART sites, and showed 
“inexplicable contempt for civil society organizations,” and refused to release 
information on its ARV programme.17  One member of the AIDS Law Project 
responsible for monitoring the status of the roll-out in the province described the 
data collection situation after a field visit as “misty up there and dusty down 
here.”   
We also see radically different provincial pictures in terms of HIV burden and 
health care provision.  The Western Cape has a lower disease burden than other 
provinces in South Africa.  Its HIV Prevalence rate among antenatal clinic 
attendees was 15.4 percent, about half of the national average of 29.5 per cent 
(Department of Health 2005).  Western Cape is not surprisingly doing the best in 
the treatment roll-out with total HAART coverage18 of over 55% by the end of 
2005 (Nattrass 2006, 5).   Why is this region so successful?  To start, it has the 
highest development index ratings in the country alongside the highest gini 
coefficient:  it is both rich and unequal.  Western Cape is the best-endowed 
province in the country for doctors, specialists and hospitals, with approximately 
73 doctors per 100 000 people (Abdullah 2005, 246-247). Geographically 
manageable, two-thirds of the Province’s population reside in greater Cape 
Town.  However, the poorest areas with the highest burdens of disease have the 
fewest facilities and the lowest number doctors per inhabitant in the city 
(Department of Health, 2004).19  Furthermore, nearly three-fourths of the 
population is dependent on public health services (Ibid.).   
The Western Cape Province more closely resembles Uganda in its political 
approach to AIDS than it does to the other provinces in South Africa.  The 
provincial tactic has emphasised openness, diversity (embracing NGOs), and 
leadership (see Naimak 2006 on South Africa and Parkhurst 2001 on Uganda). 
Public-private partnerships flourish linking pharmaceutical companies, bilateral 
                                                 
17   Notes from the fifth meeting of the Joint Civil Society Monitoring Forum meeting,  29 
August 2005, Khayelitsha, Western Cape.  Official minutes can be accessed from 
http://dedi20a.your-server.co.za/alp/images/upload/report5thmeeting.pdf, last accessed 27 
Oct. 2006.   
18   This represents the number of people on HAART in both public and private sector 
provision as a percentage of the number of people needing HAART estimated by the 
ASSA2003 demographic model.   
19   See Chopra and Saunders 2004 for a discussion of the public health disparities between 
communities within the Western Cape.   
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and multilateral donors (like USAID and the Global Fund) and the Provincial 
Government of the Western Cape.20   
Flourishing outside the national political party line—not affiliated until very 
recently with the ANC— the Western Cape was left aside by a national 
government struggling with more important political constituencies.  However, 
when the Provincial Minister crossed the floor, effectively switching sides to the 
ANC in 2005, it had immediate repercussions on the ARV programme, 
exemplifying how highly politicised this programme is. The Western Cape 
Province wanted to expand their coverage in PMTCT to provide triple therapy 
for women defined as “high transmitters.”  Still it is the only province to provide 
dual therapy.  The national regimen consists of providing the single drug 
nevirapine only.   Without any warning, the Provincial Department of Health 
was ordered at the last minute that no changes in the regimen would be 
permitted: the National Ministry had told the Province to come back into line 
with the rest of the country signaling a victory of politics over policy.  
ARV provision in the Western Cape comes in the form of a highly verticalised 
intervention.  One of the leading ARV doctors in the region compared the 
HAART rollout to a “military operation” (Naimak 2006, 13).  For example, 
ARK (Absolute Return for Kids)21 comes into a clinic where the province would 
like to begin offering ARVs with its “SWAT teams.”  The militarised language, 
coupled with claims of running development like a business and unsurpassed 
evangelical zeal, are typical of the activist-implementer in the treatment of 
AIDS.  The South African ARK Director stated in a public conference—“I feel 
like Noah building something to save South Africa!”22   
But notions of saving South Africa cannot be disentangled from the country’s 
historically-rooted, but ongoing, struggle with building a national identity.  The 
level of inequality in South African society presents particular challenges for 
providing and receiving health care for AIDS.   Relations of struggle and blame 
                                                 
20   The Provincial Government entered into partnerships with at least six other NGO or 
research-based initiatives for AIDS treatment in public facilities in the Western Cape (Naimak 
2006,7). 
21   The mission of this organisation is to prevent children from becoming AIDS orphans by 
treating their mothers with ARVs. According to their website, “ARK funds clinical staff 
required for the ramp up of treatment (“SWAT teams”), community-based adherence support 
(primarily through “patient advocates”) and the NGO team and structure to manage the 
programme. We also fund drugs, lab tests, infrastructure and key diagnostic equipment where 
necessary to prevent bottlenecks and ensure rollout is as rapid as possible” ( 
http://www.arkonline.org/projects/aids_treatment/). 
22   From the PATA Conference, Cape Town, November 2005, researcher notes. Conference 
transcript can be downloaded from 
http://www.teampata.org/proceedings.html?PHPSESSID=1adc79ba9d042eabd2a33f7f219212
12, last accessed 23 October 2006.   
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shape the way in which therapeutic citizenship must be understood.  The 
founder of one of the province’s largest ARV clinics and co-author of the 
country’s national ARV treatment guidelines concluded:  “All programmes are 
focused on the ‘oppressed’ and the ‘innocent’. . . . All of our programmes are 
focused on women and children. . . men are guilty. . . men are the perpetrators” 
(Casey 2005, 50).  Cleavages of race, class and gender continue to exacerbate 
disparities between individuals, communities and provinces in the country.  Who 
can help whom and under which circumstances would someone be legitimately 
entitled to obtain help make a difference when accessing health care.  
Heshima Clinic 
Heshima clinic is located within the oldest township in the Western Cape, dating 
back to 1927.  In many ways, Heshima clinic is a ‘best case scenario’ for ARV 
treatment in South Africa.  Unlike most of the Western Cape’s HAART 
facilities, Heshima is an integrated clinic, where ARVs are distributed together 
with primary health services, including family planning, nutritional counseling 
and limited psychological services.   The clinic is well managed and mostly 
protected from huge NGOs and their accountability demands in order to enable 
staff to conduct their clinic work with minimal disruption.  The site is also 
groomed to demonstrate success in an ongoing sub-regional political feud in the 
health sector.  Heshima has an ideal staffing ratio,23 shared leadership instead of 
a military model, and is not a research setting but an operational setting, 
according to the Regional Director responsible for the clinic.   
Before turning to descriptions of the clinical interactions, I will give just a rough 
outline of the treatment terrain in the clinic from the patient’s perspective.  In 
doing so, I am charting the “usual” path of treatment flow as I saw it most often:  
this is neither the official protocol for how treatment should happen, nor is it the 
path taken all the time. For example, often patients are so sick that they are seen 
by the doctors first and “fast tracked” onto ARVs.  However, most often, ARV 
treatment should begin with a visit to the “Patient Advocates” for the first 
counseling session.  These are the lowest paid, semi-skilled youth counselors 
who do home visits and are on-call around the clock for ARV patients.  Patient 
Advocates provide meaningful links between the “real people” and their 
caregivers and are the only service providers who are required to be “local” to 
the Heshima community.  After the session with the Patient Advocates, a patient 
should have two visits with the ARV adherence counselors.  These are highly 
skilled counselors, one male and one female, with experience in voluntary 
counseling and testing (VCT) for HIV.  They are responsible for counseling for 
adherence and detecting any potential adherence problems before patients are 
                                                 
23 There were four doctors working on site for most of the months I was working at the clinic.   
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permitted to begin ARV treatment.  A visit to the nutritionist should also take 
place, but this seemed more erratic.   A psychologist visit was prescribed for 
patients facing psychological problems that could possibly be clinically 
managed.24 
On Thursdays, meetings taking approximately three hours are held at Heshima 
clinic, and attendance by all members of the ARV “team” is mandatory.25  
Together, they decide on ARV initiation.  The terms for assessment are both 
medical and social.  Patients must have a treatment buddy, have been to 
requisite counseling sessions, have a contact person if not a proper address in the 
catchment area, and have no significant drinking or drug problems or severe 
mental illnesses.  Also, if you want treatment you must perform responsibly as a 
therapeutic citizen:  say that you will use a condom, that you will plan 
pregnancies with your doctor, try to receive appropriate government grants if not 
working, agree to eat well, refrain from traditional medicines, inform the clinic 
before traveling—especially before returning to the Eastern Cape26, and be 
adherent to your meds.  In the next section, I will draw on notes taken during 
these meetings to illustrate the difficulties of gendering the therapeutic citizens 
of Heshima Clinic. 
Border Defense of the Therapeutic State 
While the global treatment activist discourse would lead us to believe that 
Universal Human Rights to ARV provision or reproductive choice are upheld 
through global covenants, national policies and local treatment protocols, the 
reality is that the ethics of treatment are manifested in the quotidian workings of 
clinic life.  The service providers, whether Patient Advocates, adherence 
counselors or ARV physicians are left to negotiate the complex biopolitical 
imperatives of the technologies with the “social issues” of life in Heshima 
township.  Without neglecting the importance of the strictly biomedical realm of 
treatment for AIDS, my discussion will center on the “social issues” and how 
these constitute integral challenges in the treatment process.   
                                                 
24   The psychological aspect of ARV treatment and service provision is a critical and 
underemphasised area of translation that merits further research. 
25   In practice, usually one or the other of the adherence counselors attended each meeting, 
but not both.  The attendance and attention of all Patient Advocates was required.  Meetings 
were led by the Regional Director or by the doctor-in-charge of the ARV program if the 
director was unable to attend.   
26   The population movements between Eastern and Western Cape are a persistent challenge 
for the health sector, as most patients, even long-term residents of the township, can be 
expected to return “home” for traditional ceremonies, important holidays and to attend to 
family affairs.  
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At the Heshima clinic, approximately 15 people on average are considered for 
placement on ARVs each week.  There are more women than men.27  Most of 
the women are mothers; some are pregnant. In the province, at least one third of 
all HIV tests are done on pregnant women in the MTCT programme and the 
other two thirds of those testing for HIV also include mostly women.28  In spite 
of the fact that the “typical” ARV patient is a woman of childbearing age, very 
few studies have been done so far on family planning for women living with 
AIDS in the Third World. The existing ones emphasise the need to link 
contraceptive and AIDS interventions into a convenient service for women (de 
Bruyn 2005; de Bruyn 2004; Preble, Huber and Piwoz 2003; Best 2004) 
However, family planning practices are also used as meaningful performances 
of therapeutic citizenship as I will demonstrate from the ARV team meetings at 
Heshima Clinic.   
As mentioned above, once per week the entire ARV team meets to discuss the 
patients who are being “worked up” for ARV treatment.  Each file is taken up 
for discussion by the team who sit around a long table with copies of the 
abbreviated case summaries of all patients being considered to start on treatment 
during the coming week.  The dialogue on each case begins with a medical 
report from the physician responsible for the patient.  This is then followed by 
reading from a report in the file written by the social worker; however, this 
report is often missing.  Then, a summary of the home visit and personal 
situation is given orally by the Patient Advocate.  Afterward, a description of the 
adherence counseling sessions is given by the adherence counselors.  If the 
patient has seen the psychologist or nutritionist and there are further comments, 
they are given as well.     
Together with other relevant social criteria for ARV readiness, such as alcohol 
abuse or difficulty disclosing to a treatment “buddy,” contraceptive status is 
assessed during these meetings for almost all of the women who seek treatment.  
This assessment is not a simple matter of insuring that women on ARVs do not 
reproduce, although that may be the outcome.  It involves a complex negotiation 
of reproductive management for the patient’s own good.  How this “good” is 
determined involves investigation, speculation and, to some degree, 
participation of the women themselves.  The biomedical facts of AIDS treatment 
                                                 
27   Physicians interviewed in Cape Town estimated that at least 70-80% of their ARV patients 
were women because men do not come forward to receive treatment (Casey 2005, 48).   
28    Notes from Fareed Abdullah lecture, Univ. of Cape Town, 23 September 2005. 
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are considered by the ARV team in conjunction with the “social issues” that 
inevitably come forth in the case descriptions.29    
The biomedical report is the first determinant of whether a therapeutic citizen is 
potentially reproductive.  Some women who are very sick are not considered “at 
risk” of pregnancy.  One example is the case of Xoliswa.  Her case was 
discussed as a potential patient who might start on ARVs, but because she was 
so ill, the team agree that she had to be sent to the hospice center for constant 
care while beginning the treatment regime.30 Still, her doctor noted at her case 
discussion that the team will “re-discuss family planning when she’s better.”31 
Recognising that the goal of ARVs is to bring Xoliswa back to life, and in doing 
so, she will be likely to return to the possibility of reproduction.  
“Social issues,” or the situations and relationships that must be negotiated as 
part of living with AIDS into which ARV treatment plays only one part, have a 
significant effect on how a woman can be a therapeutic citizen.  One example 
comes from Phumla, a 24 year-old unemployed mother of two children, ages 
five and seven.  The family sleeps on the floor of a one room shack owned by 
Phumla’s friend and her friend’s boyfriend.  When she was being considered for 
treatment, the team’s discussion turned to her support structure.  The Patient 
Advocate reported that her sister had refused to be her treatment buddy, but now 
she has found another friend to help out in this role.  She has no regular sexual 
partner, was diagnosed positive six months earlier.  Phumla says that she wants 
another child sometime in the future, but she is currently taking the 
contraceptive injection.  Having successfully performed as a therapeutic citizen 
thus far, it was agreed that Phumla should begin ARV treatment.  However the 
“social issues” of sexual and reproductive desire, gender relations, familial 
stability, and poverty persist as limitations on Phumla’s therapeutic citizenship.   
Another example comes from Faith, a potential ARV patient who sparked a 
debate among the team members as physicians tried to negotiate their role in her 
“social issues” and her family planning.  Faith and her family are victims of 
recurrent seasonal fires attributable to cheap cookers inside flimsy shacks that 
regularly raze sections of the local informal housing settlement to the ground.  
She has two children who stay with their grandmother in a different township.  
When the team met to discuss her case, Faith had been living for months in a 
tent, pitched in another informal settlement far from her home, and was 
                                                 
29   Note that all information in this section comes from fieldnotes taken at the ARV team 
meetings which were held in English.  Names and any distinguishing information have been 
changed.   
30   The clinic has a cooperative relationship with one hospice organisation which will admit 
patients who are very ill and starting treatment in case they become sicker while suffering 
from immune reconstitution syndrome.   
31 Fieldnotes 27-09-05.   
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complaining about a lack of food.  However, Faith traveled to the Heshima 
clinic for care because she said that she wants to return to Heshima and is ready 
to start ARVs.  Her compliance with the TB treatment was reported as 
“excellent” from her files.  The programme head then asks the physician:  “So 
are you going to put her on family planning or not?”  The doctor responds, “It’s 
up to them.  If we are forcing them they are not compliant.” A different doctor 
supports the first one, “They didn’t understand that condoms are not as effective 
as the injection.  What happens if they fall pregnant?  How bad is it going to 
be?”  The programme head replies, ending the discussion, “We should be 
thinking about family planning in a broader context of family planning, not just 
contraception.”32 Here it was implied that the “social issues” of Faith’s life must 
be taken into account when her treatment regime, and its contraceptive 
component, is formulated by the physician.  However, the discussion by the 
doctors about who is responsible for making contraceptive choices and how 
these choices relate to compliance is informative.  As both of the previous 
examples demonstrate, ARV compliance must be negotiated within fundamental 
poverty constraints (where will you sleep, where can you get money, what do 
you eat) that are likely to be exacerbated by having more children.  Yet, women 
are entitled to make their own reproductive choices, and these choices may 
contravene such planning for many various reasons. Providers are relying on 
Patient Advocates’ descriptions of spaces (geographical, racial, sexual and 
economic) that they do not inhabit.  This translation dance is not always 
successful.  For example, one young woman whose name was on the pharmacy 
list for not having picked up the medicines that were prescribed for her was 
unwilling to start ARVs because she did not want to use the contraceptive 
injection, according to her patient advocate. 
The choice of drugs that make up the ARV regime must consider the probability 
of pregnancy in each woman’s case.  The possible drug interactions on a 
pregnancy is just one factor that must be considered, alongside the possible side-
effects, effectiveness and if a pregnancy is desired.  Additionally, there are 
macro-constraints of cost and availability and the disparity between regional 
health systems, which also must be considered for patients at Heshima clinic.  
One such example comes from the difficulty of prescribing the correct drug of a 
particular class necessary for the first-line regimen. Efavirenz is not 
recommended for use during pregnancy because of its link to birth-defects.   
Yet, for maintaining a woman’s health, Nevirapine needs better monitoring and 
more consistent follow-up as part of the first-line regimen than Efavirenz.33 A 
physician stated that because this rarely happens, even in the best situations in 
                                                 
32 Fieldnotes 20-10-05. 
33 Efavirenz and Nevirapine are types of medicine called non-nucleoside reverse transcriptase 
inhibitors (NNRTI). NNRTIs block reverse transcriptase, a protein that HIV needs to make 
more copies of itself. 
 19
South Africa, that they were usually anti-Nevirapine at Heshima clinic.  Instead, 
they usually make all women get a contraceptive injection34 and be on 
Efavirenz.  However, the Nevirapine is cheaper, so for patients who might be 
likely to transfer to another clinic in a province where Nevirapine is more easily 
available, like the Eastern Cape where there is significantly less funding for 
ARVs, it might be doing them a disservice to start on a better Efavirenz regime 
and then later have to switch to Nevirapine if they return home.   
On example of struggling with these issues comes from the team meeting around 
the patient Catherine, a forty-year-old mother of five children.  Catherine is 
married to an HIV positive man and depends on his government disability grant 
for support.  She lives in a room that shelters seven families.  It was in her file 
from the case work-up with the adherence counselor and physician that she was 
not on family planning, but had been encouraged to start.  Catherine had already 
been in counseling to start ARVs months earlier, but she disappeared when the 
time had come to actually begin them.  It was reported at the team meeting that 
she had said that it was because of the six other families that she did not want to 
start the drugs.   It was noted that her living situation has not changed, but now 
she is so sick that she is ready to start the ARVs.  Catherine is taking the 
contraceptive injection, and the doctor asks if it is current.  After looking at her 
chart, it is reported that it is not.  She is started on the ARV regimen that 
includes Nevirapine, just in case she falls pregnant.  
Discourses of liberal individualism, choice-making and reproductive rights are 
framing the policies and practices at Heshima Clinic.  Yet, a patient was noted to 
have “just started on contraception two weeks before because we forced her.”35  
Others are described as “being on family planning specifically for the ARVs.”  
Together with the “social issues,” women on ARVs must add the dual 
possibility of an AIDS-infected baby and one with birth defects attributable to 
the mother’s treatment regime. ARV treatment complicates the negotiating 
logics, already difficult to disentangle from poverty and fertility desires, for 
realising reproductive choice.   
Is the very nature of being a woman with AIDS who is the mother of an infected 
child in the Western Cape excluded from the possibility of therapeutic 
citizenship because it can be assumed that you have “failed” PMTCT?  The 
Provincial Deputy Director responsible for the ARV programme stated in a 
public lecture that in Khayelitsha where MSF has had the longest running ARV 
programme in Africa, they have been so effective with their PMTCT programme 
that today if a child is born with AIDS the presiding doctor will call all the other 
                                                 
34  The injection is favored for its effectiveness and because its provider-dependency makes 
for easier monitoring by the clinic staff.   
35 Fieldnotes 20-10-05. 
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doctors to come and see.  What will happen as more PMTCT services become 
available throughout the country and the Third World?  Will women be 
penalised for bearing a positive child?  Will these debates follow the examples 
of prenatal testing and genetic disorders?   
The example of Vusiwa provides us with a twist on the notion of treating the 
mother with ARVs to protect the child, as in her case, the child’s treatment 
resulted in a commitment to treatment by her mother.   Vusiwa, a 31 year-old 
mother of an eight-year old and a three-year old child, was afraid to start ARV 
treatment.  She was sent to the psychologist because it was reported that she had 
not processed her anger from her previous relationship where she was infected 
with HIV.  She is now in a relationship were she gets support from her boyfriend 
who is reported to be HIV negative.  Her three-year-old daughter has been on 
ARVs since 2003, and now Vusiwa feels confident about getting her own 
treatment at the same time as her daughter.  At the time of the team meeting 
report, Vusiwa’s CD4 count was down to 100.  It was reported that she does not 
know if she wants to have more children, but for now she is using family 
planning and condoms.36  
Clinic level data remind us that it is worth explicit research consideration that 
women with AIDS do get pregnant, whether they are on treatment or not.  As 
PMTCT expands into HAART in developing countries, more attention is needed 
to how mothers and their children negotiate AIDS care, and as such act as 
gendered therapeutic citizens.  These examples suggest that while we can chart 
some of the parameters of the female therapeutic citizen, we cannot adequately 
describe the socially structured and heterogeneous processes that result from the 
decisions taken on these performances. ARVs and family planning for women 
do not come as a consistent imposition of biopolitical discipline relying on 
medical authoritarianism, as one might expect given the political, racial and 
economic history of the case.  Instead, we see complex negotiations between 
“ought” and “can”, “possibility” and “probability”, ethics and protocols.  All of 
which are conducted on the basis of highly imperfect information, requiring 
multiple layers of translation within a context of complicated and sometimes 
competing agenda. Women and their providers are pragmatically negotiating a 
very messy terrain of “social issues” and complicated biosociality in which the 
fact that women are regularly over-victimised does not mean that they 
adequately control their sexual or reproductive lives.  It is in these interactions 
where women do have input into the decisions made over their health, even in a 
formal, medical setting, where the possibility of performing as a gendered 
therapeutic citizen becomes important. 
                                                 
36 Fieldnotes 27-09-05. 
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Biopolitical technologies versus “social issues”: 
Counselling the Therapeutic Citizen for Family 
Planning 
The counseling context for ARVs in South Africa is an overdetermined 
biopolitical arena into which ethnographic descriptions only scratch superficially 
along the grid.  The historical legacy of apartheid predisposes us to question the 
motivations of health professionals, as the entire system of public health under 
apartheid was structured and staffed to insure that nonwhites were well enough 
to work but without excess energy for political struggle.  Critical work on 
apartheid public health emphasises the elements of what Stoler terms biologised 
racism that “establishes a positive relation between the right to kill and the 
assurance of life” (1995, 84).  Yet this authoritarian endowment has also 
resulted in a contemporary culture that emphasises Rights in post-apartheid 
South Africa. Reproductive rights are enshrined in the South African 
constitution, as are the rights of people living with HIV/AIDS.37  Not only are 
these codified forms of authority, but also Rights are popularised notions as the 
earned inheritance of all contemporary South African citizens who have come 
out of the struggle.   
In the previous section, we saw the “team” of ARV experts trying to negotiate 
these ethical dilemmas in ways that will determine when, how, and if, a woman 
will receive access to ARV treatment at the clinic.  However, when a woman is 
being “worked up” for ARV treatment, it is the sessions on adherence 
counseling that are most central in forming the identity of the therapeutic 
citizen.  The hard-working adherence counselors take patients alone, or with 
their “treatment buddies,” into one of the counseling bungalows and try to 
counsel them on how to negotiate the biosocial terrain of treatment.  This can 
involve the dissemination of information, the management of concerns and 
fears, and the transmission of values within the counseling context.38   
One example of the kinds of negotiations around family planning while on ARV 
treatment comes from a young couple from the Eastern Cape.  Nancy and her 
husband came in for the second counseling session with the female adherence 
counselor.  They have been living in an informal camp for “temporary” housing 
since 1999 and have a seven-year-old child who lives with his grandparents in 
                                                 
37 Launched in 1992, the Charter of Rights on AIDS and HIV is a bill of rights for people 
living with HIV/AIDS in South Africa and forms the legal basis for ending discrimination and 
promoting public health  (http://alp.org.za/images/upload/3rdAids%20finalss%20append.pdf). 
38   Material in this section on counseling comes from fieldnotes written by the author at the 
time of simultaneous translation of the interactions into English.  All sessions were observed 
with explicit permission from all participants involved, and all names are pseudonyms.   
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their home region but entitles them to state-funded child support.  The adherence 
counselor explained to Nancy and her husband: 
The drugs are not forced on people . . . the reason why we don’t push people on 
these drugs is because it is a lifetime commitment.  You are both young, and 
maybe one day you will want children. If the girl wants the drugs then she will 
have to hear all about what she must know.  She must take her drugs every day.  
The virus is so clever that if you skip one day the virus will build resistance.  The 
drugs suppress the virus . . . you’re rebuilding your body and it becomes strong 
and the patient will live longer.  These drugs we’re going to give her are three 
different regimens:  two you take twice a day and one at night.  But if you decide 
that you want to have children, we will take out the one at night and replace it 
with Nevirapine.   
But you must stay together.  Talk together and come and sit down with the doctor 
so that you can have the chances explained.  If you [referring to the husband] are 
HIV negative again then your chances are higher to get a child.  You can be 
referred to a fertility clinic, and they will explain your chances of getting a child.  
Nancy has told the doctor that she doesn’t need a baby now, so it’s OK to start her 
on these three regimens.  She cannot fall pregnant taking Stavodine because it can 
affect the pregnancy.  This is why she is supposed to use contraceptives.   If can 
becomes pregnant, the child won’t be normal.   
Being a successful therapeutic citizen requires choice, commitment, spousal 
communication, and control of a woman’s fertility.  Implicitly, it is recognised 
that a health child could be the potential reward for a job well done.  The 
meaning that ARV treatment provides to couples is that they can resume their 
lives, and in doing so, reproduction will mark success.   
Pregnant, young Thandi came in for her second counseling session with the 
male adherence counselor, bringing her mother to act as her “treatment buddy” 
in hopes of getting quickly on ARVs to treat her own disease and protect her 
unborn baby.  After explaining the virus and the drugs, the counselor advised 
Thandi’s mother: 
She can come for the PMTCT programme so that the virus can be suppressed.  
The virus is in the blood so a child can be infected during pregnancy, labor and 
breastfeeding so these drugs, they’re made to prevent that.  The results are 
positive so the Americans said, ‘So if this is working, why don’t they give 
everyone the drugs so that the mother can raise her child on her own.  At the same 
time, the English people said that this is good, now you are preventing the mother 
and child, but what about their fathers?’ So in England they introduced these 
drugs to everybody, so now everyone can have a prolonged life. 
Linking the drugs with international support may have been an attempt to reduce 
their stigma and build their associated credibility, in which my own presence as 
a foreign observer in the room may have provided a silent complicity.  It also 
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provides an example of the external-orientation of the ARV programme 
specifically and the Western Cape health department in general.  When the 
national government cannot be counted on to support the ARV programme, 
distant alliances are constructed within the viable discourses of cost-effective 
child raising by poor African women.   
The counselor continued to explain to Thandi and her mother the biosocial 
regimen of childbearing on ARVs: 
Let’s say you don’t want only one baby, and maybe you’ll get married.  These 
days you must suppress the virus so if you want another baby and your CD4 count 
is high [you can have one].  The first few months when we start treatment, we will 
draw blood to see the progress of the virus in your body. If the CD4 is greater than 
450 and the virus is suppressed, then you can have another baby.  If the CD4 is 
over 450, the virus is undetectable, and the chances of the baby being affected are 
slim.  It depends on your partner.  If he is also positive and has a suppressed virus, 
then the doctor will agree that you can have another baby.  Now your CD4 count 
is low, and after this baby is born you can go for contraception.  Afterward you 
must use condoms all the time. You are on treatment and your boyfriend is not, so 
if you don’t use a condom he will need treatment and your drugs won’t do.  It is 
dangerous to sleep with somebody not on treatment.  We say to use condoms 
because the contraception is not 100% safe.  Sometimes a condom can be torn, 
then you must also be using contraception -- maybe Petogen or Depo Provera.39  
We always say to use contraception and condoms both.  When you need another 
baby and both you and your partner have the virus undetectable then the doctor 
will arrange for you for that.  This doesn’t mean that if you are HIV positive you 
can’t get a child, but if your CD4 is high we must protect the child.   
The previous explanation by the counselor illustrates many of the complexities 
of reproducing the therapeutic citizen.  The use of conditional language, “if, 
then” implies a management strategy and a controllable outcome.  If, both 
parties are able to manage their sexual encounters and their viruses, then they 
have the chance of achieving a healthy child.  The clinic team is there to help 
protect the potential child through management of the virus.  However, the 
corporeal sign, drawn through the blood, will tell if a patient can reproduce or 
not.  Furthermore, the regime of recommended reproduction is quite 
complicated, using dual method protection of condoms and contraceptive 
injections, and it is made more so in the context of the patients’ “social issues.”   
In the counseling session described, after the extensive explanation of the 
possibility that she might want another child in the future, Thandi astutely 
ruptured the protocol of possibilities with the concern for her immediate, already 
pregnant, situation.  Thandi asked the counselor at this point:  “Are those pills 
not going to cause any problems for my baby [currently in utero]?”  While the 
                                                 
39   Both are injectable family planning methods that provide contraceptive protection for 
twelve weeks.   
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professional counselor had been quite effectively explaining the protocol of how 
a woman on ARVs might continue with a “normal” reproductive life, the 
patient’s response signals a pragmatism that brings forth the contradictions in 
gendering the therapeutic citizen.  These protocols are based on forethought, 
evidence-based planning, and meticulous control of reproductive decision-
making.  They are not necessarily relevant for the woman who finds herself 
pregnant with a low viral load and need for ARVs for her own virus as well as 
for her child.  The understandings gained by in-depth research on reproductive 
decision-making (cf. Bledsoe 2002; Johnson-Hanks 2002, Greenlaugh 1995) 
show that choices over childbearing and methods for its prevention are 
contingent upon women’s perceptions of their physical and social situation, and 
that the circumstances of auspicious childbearing vary greatly across individuals 
and communities.  This attention to both the particular, and the social, has not 
been incorporated at all into the new and more complex settings of AIDS 
treatment.  Instead, as a recent study demonstrates, a development intervention 
matrix on “pregnancy status, HIV status and service delivery needs” with two 
separate columns for “wants future pregnancy” and “does not want future 
pregnancy” is still used (Preble, Huber and Piwoz 2003).  If there is any 
reasonable hypothesis to be made on the reproductive decision making of 
women living with AIDS, it would be that the issues of contingency become 
even more pronounced in their lives than in the lives of women who are not 
currently struggling with the virus.  
Gendering the Therapeutic Citizen?  Future 
Directions 
Therapeutic citizenship exists as “a form of stateless citizenship whereby claims 
are made on a global order on the basis of one’s biomedical condition, and 
responsibilities worked out in the context of local moral economies” (Nguyen 
2006, 142).  The structures of both the global order and the local moral 
economies around the reproductive behavior of women on ARV treatment seem 
to exist simultaneously beyond impassable terrain, yet call for articulation to 
form the basis for action and activism. Evidence from fieldwork in the Western 
Cape suggests that these matters of clinical concern that come at the interface of 
“social issues” and ARV technologies are so jagged that they do not produce a 
reflexive response.  We cannot simply use existing knowledge on ARV 
treatment regimes wedded together with models of reproductive desires and 
contraceptive use.   Therefore, the performance aspect of the therapeutic citizen 
becomes invaluable, as does the translation effort of the Patient Advocate, who 
is situated in a no-man’s land of the biopolitical state – neither fully citizen nor 
sovereign.   
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Paul Roux, a well known Cape Townian physician and founder of the pediatric 
HIV clinic at Groote Schuur Hospital, described his treatment experiences with 
mothers on ARVs.  These women have high rates of pregnancy when they feel 
that they have become healthy again with ARVs.  A practitioner and pragmatist, 
he explained:  “You can’t expect to restore someone to personhood and not 
allow them to procreate.”40  How then will it become possible for women to be 
full “therapeutic citizens” whose gendered claims are taken seriously within 
both the global order and the local moral economy?  
Implicit in most of the literature, discussions and activism is the notion that HIV 
positive women who are pregnant have often discovered their status in the 
process of antenatal care, not that they have knowingly conceived a pregnancy 
while aware of their positive status.  Even activist organisations in South Africa 
and Uganda have had a difficult time dealing with the possibility of 
reproductively active HIV positive women.  Therapeutic citizens, we might be 
led to believe, do not reproduce.   
But as the case study here demonstrates, women on ARVs do reproduce, thus it 
is important for research to focus more specifically on the gendered realities of 
AIDS treatment.  Do women who are already therapeutic citizens and 
biomedical beings, and who have become accustomed to routine monitoring, 
biosocial audits and complex negotiations between people and pills attribute 
different meanings to the clinic experience?  If one’s life is highly medicalised, 
does then the demand for physician interaction, specialized decision making and 
incessant intervention in the reproductive process become routinised to the point 
of greater tolerability and increased effectiveness?  Is it reasonable to expect that 
women on ARVs take a far more active role in evaluating, planning and 
controlling their reproductive lives than women who are not on AIDS treatment?  
How can we meaningfully integrate “social issues” into our understandings as 
more than just justifications for “noncompliance”?  These issues coalesce 
around questions of the meanings of care, looking after one’s self, and the extent 
to which “self” and pregnancy are juxtaposed.  
What are the implications of the conceptual difficulties of gendering the 
therapeutic citizen?  Perhaps this speaks to the limits of HIV/AIDS in people’s 
lives:  the disease is not determining in ways that are clear, unilateral, functional 
or consistent.  If women with AIDS reproduce in ways that bear a striking 
resemblance to women without AIDS, why should this be so surprising?  Are 
women with AIDS simply reflecting yet another identity, positioned 
strategically or haphazardly alongside the many other indices of social 
evaluation in South Africa (race, class, religion, etc.)?  Women on ARVs who 
want to become pregnant while remaining good therapeutic citizens must 
                                                 
40   Paul Roux, presentation at the PATA Conference, Cape Town 29 November 2005.  
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exercise a vast and steadfast discipline of the self and the sexual “other,” and 
additionally must master the performance and pragmatism of dealing effectively 
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